UPMC logo UPCI logo NCI logo
About Us | News | Jobs | Giving | Volunteer | Contact Us
Search

Prostate Cancer

Partin Coefficient Table I: PSA = 0.0 – 4.0 ng/ml

This table shows the probability of having each of the four pathologic stages of prostate cancer based on Gleason score, clinical stage and a PSA level between 0.0 and 4.0 ng/ml.


Examples

  • A man with a PSA level of 3.2 ng/ml, a Gleason score of 3 and a clinical stage of T1b has an 80% chance of having organ-confined disease.

  • A man with a PSA level of 2.7 ng/ml, a Gleason score of 6 and a clinical stage of T2c has a 4% chance of seminal vesicle involvement.

PSA = 0.0 – 4.0 ng/ml
Probability of Pathologic Stage (%)
Clinical Stage
Gleason score
Pathologic stage

T1a

T1b

T1c

T2a

T2b

T2c

T3a

2-4
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement


90



9


0


0


80



19


1


0


89



10


1


0


81



18


1


0


72



25


2


0


77



21


2


0













5
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement


82



17


1


0


66



32


2


1


81



18


1


0


68



30


2


0


57



40


3


1


62



34


3


1


40



51


7


2

6
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement


78



19


1


1


61



35


2


2


78



21


1


0


64



34


2


1


52



43


3


2


57



37


4


2


35



53


7


5

7
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement














43



44


6


6


63



31


4


1


47



45


6


2


34



51


10


5


38



45


12


5


19



52


19


9

8-10
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement














31



43


11


14


52



34


9


4


36



47


12


5


24



48


17


10


27



42


21


10












… lack of sufficient data to calculate probability

Reference: Partin AW, Kattan MW, Subong EN, Walsh PC, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451. Copyrighted 1997, American Medical Association. Reprinted with permission.



About This Web Site | Give Us Your Feedback | Privacy Statement | Disclaimer | Informatics Web Resources

© UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811 | PCI-INFO@upmc.edu |
Send questions and comments to UPCIwebupdates@upmc.edu